Superoxide anion radical scavenging property of catecholamines

Luminescence - Tập 28 Số 4 - Trang 450-455 - 2013
Aleksandra Kładna1, Paweł Berczyński2, Irena Kruk2, Teresa Michalska2, Hassan Y. Aboul‐Enein3
1Department of History of Medicine and Medical Ethics, Pomeranian Medical University, Rybacka 1, 70-204 Szczecin, Poland
2West Pomeranian University of Technology Szczecin Institute of Physics al. Piastów 48 70‐311 Szczecin Poland
3Pharmaceutical and Medicinal Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki, Cairo 12311, Egypt

Tóm tắt

ABSTRACTThe direct effect of the four catecholamines (adrenaline, noradrenaline, dopamine and isoproterenol) on superoxide anion radicals () was investigated. The reaction between 18‐crown‐6‐ether and potassium superoxide in dimethylsulfoxide was used as a source of . The reactivity of catecholamines with was examined using chemiluminescence, reduction of nitroblue tetrazolium and electron paramagnetic resonance spin‐trapping techniques. 5,5‐Dimethyl‐1‐pyrroline‐N‐oxide was included as the spin trap. The results showed that the four catecholamines were effective and efficient in inhibiting chemiluminescence accompanying the potassium superoxide/18‐crown‐6‐ether system in a dose‐dependent manner over the range 0.05–2 mm in the following order: adrenaline > noradrenaline > dopamine > isoproterenol, with, IC50 = 0.15 ± 0.02 mm 0.21 ± 0.03 mm, 0.27 ± 0.03 mm and 0.50 ± 0.04 mm, respectively. The catecholamines examined also exhibited a strong scavenging effect towards when evaluated this property by the inhibition of nitroblue tetrazolium reduction (56–73% at 1 m concentration). A very similar capacity of scavenging was monitored in the 5,5‐dimethyl‐1‐pyrroline‐N‐oxide spin‐trapping assay. The results suggest that catecholamines tested may involve a direct effect on scavenging radicals. Copyright © 2013 John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

Januszewicz W, 1972, Katecholaminy, Rola w chorobach układu krążenia

Hoffman BB, 1996, Goodman's the pharmacological basis of therapeutics, 199

10.1016/j.jaci.2005.12.1310

10.1016/j.ajem.2005.10.008

10.1016/j.cbi.2008.09.023

10.1007/s12013-009-9043-x

10.1017/S0029665110000054

10.1016/j.abb.2010.04.005

10.1016/j.biocel.2006.07.001

10.1016/j.freeradbiomed.2005.03.003

10.1023/A:1007934229968

10.1042/bj3130017

10.1016/j.freeradbiomed.2009.09.009

Bartosz G, 2003, Wolne rodniki w przyrodzie

10.1063/1.555739

10.1002/bio

10.1016/S0076-6879(84)05010-2

10.1021/jf00035a014

10.1016/0003-9861(80)90323-9

10.1021/jf010086v

10.1111/j.1751-1097.1978.tb07001.x

10.1002/bio.1283

10.1021/ja00714a010

10.1111/j.1751-1097.1978.tb06980.x

10.1021/ic00144a033

10.1021/jf020540a

10.1002/anie.201000044

10.1021/ja002455u